SCHEMBL9258791

SCHEMBL9258791

O=C(O)N1Cc2ccccc2Sc2ccc(Cl)cc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B3 P37058 4/20 0.56
▸ BCHE P06276 3/20 0.53
▸ ACHE P22303 3/20 0.53
▸ HPGD P15428 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ MEN1 O00255 4/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ LMNA P02545 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ GMNN O75496 2/20 0.45
▸ PMP22 Q01453 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ RAD52 P43351 1/20 0.44
▸ KCNK9 Q9NPC2 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8886187 0.89 HSD17B3 (0.56) HSD17B3BCHEACHEHPGDL3MBTL1
SCHEMBL9376652 0.78 HPGD (0.49) HSD17B3BCHEACHEHPGDL3MBTL1
SCHEMBL8885929 0.77 BCHE (0.44) HSD17B3BCHEACHEL3MBTL1MEN1
SCHEMBL9376656 0.77 BCHE (0.48) HSD17B3BCHEACHEHPGDL3MBTL1
SCHEMBL9197912 0.76 HDAC3 (0.52) BCHEACHEMEN1KMT2ALMNA
SCHEMBL9196350 0.74 BCHE (0.52) BCHEACHEL3MBTL1MEN1KMT2A
SCHEMBL8786898 0.74 BCHE (0.46) HSD17B3BCHEACHEMEN1KMT2A
SCHEMBL9272291 0.73 MEN1 (0.48) HSD17B3BCHEACHEMEN1KMT2A
SCHEMBL8885925 0.73 PTGER1 (0.49) HSD17B3BCHEACHEMAPTALDH1A1
SCHEMBL676665 0.73 MEN1 (0.69) HSD17B3MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5461046-A Analgesics G. D. SEARLE & CO. (US) 1995-10-24 — — US claimed
US-5461046-A Analgesics G. D. SEARLE & CO. (US) 1995-10-24 — — US disclosed
US-5393747-A Substituted dibenzoxazepine compounds for the treatment of convulsions, ischemia and other diseases responsive to prostaglandin-E2 antagonists G. D. SEARLE & CO. (US) 1995-02-28 — — US disclosed
EP-0583408-A1 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G.D. SEARLE & CO. (US) 1994-02-23 — — EP disclosed
US-5283240-A Administering prostaglandin antagonists G. D. SEARLE & CO. (US) 1994-02-01 — — US disclosed
US-5182272-A 8-substituted-dibenz[b,f][1,4]oxazepine-10(11)-carboxylic acid, substituted hydrazides, pharmaceutical compositions, and methods for treating pain G. D. SEARLE & CO. (US) 1993-01-26 — — US disclosed
WO-1992019605-A1 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G. D. SEARLE & CO. (US) 1992-11-12 — — WO disclosed
EP-0512399-A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use G.D. Searle & Co. (US) 1992-11-11 — — EP disclosed
Send feedback